Aaron G.L. Fletcher
InvestorManaging Partner at Bios Partners · Director at Abilitech Medical · Board director at Actuate Therapeutics · Board director at Lung Therapeutics
Fort Worth, Texas
Writes $100K – $5M checks · typically $1.5M
Find your path to Aaron
194 people in our graph share verified history with Aaron — schools, employers, funds. One of them is your warm intro.
About
Managing director of Bios Partners and founder/president of Bios Research, providing healthcare public equity research. Holds a PhD in biochemistry from Colorado State University and is a visiting professor at Dallas Baptist University with 10+ years in biotech/healthcare equity consulting.
Contact· self-published, not guessed
Director at Abilitech Medical
Intro paths
In turn, Aaron can intro founders to Abilitech Medical's investors below.
Abilitech Medical's investors · 3
Co-founders at Abilitech Medical
Board director at Actuate Therapeutics
Intro paths
In turn, Aaron can intro founders to Actuate Therapeutics's investors below.
Actuate Therapeutics's investors · 4
Co-founders at Actuate Therapeutics
Board director at Lung Therapeutics
Intro paths
In turn, Aaron can intro founders to Lung Therapeutics's investors below.
Lung Therapeutics's investors · 2
Experience
- AbiliTech MedicalBoard Membercurrent2017 — present
- Cognition TherapeuticsBoard Membercurrent2015 — present
- Actuate TherapeuticsBoard Membercurrent2015 — present
- Bios PartnersFounder & General Partnercurrent2014 — present
- Lung Therapeutics, Inc.Board Membercurrent2014 — present
- Bios Research, LLCFounder and Presidentcurrent2012 — present
- Dallas Baptist UniversityVisiting Professor of Biochemistrycurrent2008 — present
- UT Southwestern Medical CenterPostdoctoral Fellow2008Dallas/Fort Worth Area
- Colorado State UniversityPHD Candidate2004 — 2007
- York CollegeLaboratory Assistant1999 — 2003
Skills & more
From Aaron's professional profile.
Deals · 3
Actuate TherapeuticsBoard seat
via Bios Partners · filed Mar 2024 · $5M raise
Cue BiopharmaBoard seat
via Bios Partners · filed Nov 2022 · $30M raise
Lung TherapeuticsBoard seat
via Bios Partners · filed Apr 2022 · $15M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Bios Partners
Network7
Investors connected to Aaron in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Aaron G.L. Fletcher?
- Managing director of Bios Partners and founder/president of Bios Research, providing healthcare public equity research. Holds a PhD in biochemistry from Colorado State University and is a visiting professor at Dallas Baptist University with 10+ years in biotech/healthcare equity consulting.
- Where does Aaron G.L. Fletcher work?
- Aaron G.L. Fletcher is Managing Partner at Bios Partners and Board director at Actuate Therapeutics and Board director at Lung Therapeutics.
- What check size does Aaron G.L. Fletcher write?
- Aaron G.L. Fletcher typically writes checks of $100K – $5M.
- What boards does Aaron G.L. Fletcher sit on?
- Aaron G.L. Fletcher holds tracked board seats at Actuate Therapeutics, Cue Biopharma, Lung Therapeutics.
- Where did Aaron G.L. Fletcher go to school?
- Aaron G.L. Fletcher studied at Colorado State University (Doctor of Philosophy - PhD, Biochemistry); York University - Nebraska (Bachelors of Science).
Same school
Also attended Colorado State University145
+ 139 more
Also attended York University - Nebraska1
Shared employers
Also worked at Bios Research, LLC1
Also worked at Dallas Baptist University3
Also worked at UT Southwestern Medical Center35
+ 29 more
Also worked at Colorado State University34
+ 28 more